alexa Congenital and Acute Kidney Disease: Translational Rese
ISSN: 2327-5146

General Medicine: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Congenital and Acute Kidney Disease: Translational Research Insights from Zebrafish Chemical Genetics

Shahram Jevin Poureetezadi and Rebecca A Wingert*
Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556, USA
Corresponding Author : Rebecca A Wingert
Department of Biological Sciences
University of Notre Dame, 100 Galvin Life Sciences
Notre Dame, IN 46556, USA
Tel: (574)-631-0907
Fax: (574)-631-7413
E-mail: [email protected]
Received July 15, 2013; Accepted August 20, 2013; Published August 27, 2013
Citation: Poureetezadi SJ, Wingert RA (2013) Congenital and Acute Kidney Disease: Translational Research Insights from Zebrafish Chemical Genetics. Gen Med (Los Angel) 1:112. doi: 10.4172/2327-5146.1000112
Copyright: © 2013 Poureetezadi SJ, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at
DownloadPubmed DownloadScholar Google
 

Abstract

Today, acute kidney injury (AKI) and congenital anomalies of the kidney and urinary tract (CAKUT) represent major issues in healthcare. Both AKI and CAKUT can lead to end stage renal disease (ESRD) that requires life-long medical care with renal replacement therapy. Renal replacement by dialysis is intensive, and kidney transplantation is restricted by organ availability. These limitations, along with the growing epidemic of patients affected by kidney disease, highlight the significant need to identify alternative ways to treat renal injury and birth defects. Drug discovery is one promising avenue of current research. Here, we discuss zebrafish chemical genetics and its latent potency as a method to rapidly identify small molecule therapeutics to accelerate recovery after AKI. Specifically, we review two groundbreaking studies that have recently provided a template to screen for compounds that expand the renal progenitor field in development that were capable of treating AKI in both the zebrafish and the mouse. These new findings demonstrate that drug discovery using zebrafish can be used for relevant translational research to identify clinical interventions for renal conditions in humans.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords